daunorubicine
Showing 1 - 5 of 5
Leukemia, Myelocytic, Acute Trial in Italy (Identification of appropriate therapies according to risks factors, Daunorubicine,
Unknown status
- Leukemia, Myelocytic, Acute
- Identification of appropriate therapies according to risks factors
- +2 more
-
Gallarate, Italy
- +35 more
Nov 14, 2017
Chronic Myeloid Leukemia Trial in Poitiers (Imatinib mesylate 600 mg, Cytarabine, Daunorubicine)
Terminated
- Chronic Myeloid Leukemia
- Imatinib mesylate 600 mg
- +2 more
-
Poitiers, FranceUniversity Hospital
Nov 25, 2005
De Novo Akute Myeloid Leukemia (AML), Secondary Acute Myeloid Leukemia (AML), Refractory Anemia With Excess of Blasts in
Unknown status
- De Novo Akute Myeloid Leukemia (AML)
- +2 more
- Cytarabine
- +5 more
-
Hannover, GermanyHannover Medical School
Nov 17, 2005